Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma

Fig. 4

miR-25 overexpression in CD138+ plasma cells is associated with poor overall and progression-free survival. Kaplan–Meier survival curves for A overall survival (OS) and B progression-free survival (PFS) of the screening cohort, and for C OS of the MMRF CoMMpass validation cohort, according to CD138+ miR-25 expression. p-values calculated by log-rank test

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us